Target Name: ENHO
NCBI ID: G375704
Review Report on ENHO Target / Biomarker Content of Review Report on ENHO Target / Biomarker
ENHO
Other Name(s): Energy homeostasis associated | Energy homeostasis-associated protein | Adropin | energy homeostasis-associated protein | UNQ470 | OTTHUMP00000215883 | energy homeostasis associated | ENHO_HUMAN | GAAI470 | C9orf165

ENHO: A Protein Regulator of Energy Homeostasis

ENHO, or Energy Homeostasis Associated, is a protein that plays a crucial role in maintaining energy balance within the human body. It is a key regulator of energy homeostasis, which is the ability of the body to maintain a stable level of energy intake and output. ENHO is associated with a variety of physiological processes in the body, including metabolism, inflammation, and stress.

As a drug target, ENHO has the potential to be a treatment for a variety of disorders. For example, ENHO is often associated with obesity and type 2 diabetes, conditions that are characterized by uncontrolled energy intake and metabolism. By targeting ENHO, researchers may be able to develop new treatments for these disorders.

ENHO is also a potential biomarker for a variety of conditions. Its expression has been observed in a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. By studying the expression of ENHO in these conditions, researchers may be able to develop new diagnostic tools and treatments.

One of the key challenges in studying ENHO is its complex structure and function. ENHO is a protein that is composed of multiple domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. These domains give ENHO its unique structure and function.

The extracellular domain of ENHO is responsible for its ability to interact with other proteins and molecules outside of the cell. This domain is involved in a variety of interactions, including with enzymes that are involved in energy metabolism.

The transmembrane domain of ENHO is responsible for its ability to interact with the cell membrane and the cytosol. This domain is involved in the regulation of ion channels and the transport of nutrients and waste products across the membrane.

The intracellular domain of ENHO is responsible for its ability to interact with other proteins and molecules within the cytosol. This domain is involved in the regulation of protein stability and the detoxification of harmful substances.

ENHO is involved in a variety of physiological processes in the body, including energy metabolism, inflammation, and stress. It is a key regulator of energy homeostasis, which is the ability of the body to maintain a stable level of energy intake and output. ENHO is also involved in the regulation of ion channels, the transport of nutrients and waste products across the membrane, and the detoxification of harmful substances.

As a drug target, ENHO has the potential to be a treatment for a variety of disorders. For example, ENHO is often associated with obesity and type 2 diabetes, conditions that are characterized by uncontrolled energy intake and metabolism. By targeting ENHO, researchers may be able to develop new treatments for these disorders.

ENHO is also a potential biomarker for a variety of conditions. Its expression has been observed in a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. By studying the expression of ENHO in these conditions, researchers may be able to develop new diagnostic tools and treatments.

One of the key challenges in studying ENHO is its complex structure and function. ENHO is a protein that is composed of multiple domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. These domains give ENHO its unique structure and function.

The extracellular domain of ENHO is responsible for its ability to interact with other proteins and molecules outside of the cell. This domain is involved in a variety of interactions, including with enzymes that are involved in energy metabolism.

The transmembrane domain of ENHO is responsible for its ability to interact with the cell membrane and the cytosol. This domain is involved in the regulation of ion channels and the transport of nutrients and waste products across the membrane.

The intracellular domain of ENHO is responsible for its ability to interact with other proteins and molecules within the cytosol. This domain is involved in the regulation of protein stability and the detoxification

Protein Name: Energy Homeostasis Associated

Functions: Involved in the regulation of glucose homeostasis and lipid metabolism

The "ENHO Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ENHO comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ENKD1 | ENKUR | ENO1 | ENO1-AS1 | ENO1P1 | ENO1P4 | ENO2 | ENO3 | ENO4 | ENOPH1 | eNoSC Complex | ENOSF1 | ENOX1 | ENOX1-AS2 | ENOX2 | ENPEP | ENPP1 | ENPP2 | ENPP3 | ENPP4 | ENPP5 | ENPP6 | ENPP7 | ENPP7P10 | ENPP7P12 | ENPP7P7 | ENSA | ENSAP2 | ENTHD1 | ENTPD1 | ENTPD1-AS1 | ENTPD2 | ENTPD3 | ENTPD3-AS1 | ENTPD4 | ENTPD5 | ENTPD6 | ENTPD7 | ENTPD8 | ENTR1 | ENTREP1 | ENTREP2 | ENTREP3 | env | ENY2 | EOGT | EOLA1 | EOLA1-DT | EOLA2 | EOLA2-DT | EOMES | EP300 | EP300-AS1 | EP400 | EP400P1 | EPAS1 | EPB41 | EPB41L1 | EPB41L1-AS1 | EPB41L2 | EPB41L3 | EPB41L4A | EPB41L4A-AS1 | EPB41L4A-DT | EPB41L4B | EPB41L5 | EPB42 | EPC1 | EPC2 | EPCAM | EPCAM-DT | EPDR1 | EPG5 | EPGN | EPHA1 | EPHA1-AS1 | EPHA10 | EPHA2 | EPHA2-AS1 | EPHA3 | EPHA4 | EPHA5 | EPHA5-AS1 | EPHA6 | EPHA7 | EPHA8 | EPHB1 | EPHB2 | EPHB3 | EPHB4 | EPHB6 | Ephrin Receptor | EPHX1 | EPHX2 | EPHX3 | EPHX4 | EPIC1 | EPIST | Epithelial Sodium Channel (ENaC) | EPM2A